The Asian medical cannabis market could be worth an estimated US$5.8 billion by 2024, Prohibition Partners, a market intelligence and strategic consultancy firm, has found in its latest report. According to analysis, which was released this Thursday, if legislation is introduced in a number of the continent's major markets, this estimate could quadruple by 2027. Read More